Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000885590-15-000065)

Filing Details

Accession Number:: 0000885590-15-000065
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-03 16:54:05
Reporting Period:: 2015-07-30

Filing Date:: 2015-08-03
Accepted Time:: 2015-08-03 16:54:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Valeant Pharmaceuticals International Inc.	VRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1645041	L. Robert Rosiello	400 Somerset Corporate Boulevard Bridgewater NJ 08807	Evp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2015-07-30	7,171	$253.99	440,971	No	4	P	Direct
Common Stock, No Par Value	Acquisiton	2015-07-31	704	$257.25	441,675	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

This number represents the weighted average purchase price for all sales of common stock purchased by the reporting officer.